Ticker
OVIDCompany Name
OVID THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 42.09M | 4.72 | $ 8.92M |
3/31/2025 | $ 45.92M | 4.93 | $ 9.31M |
12/31/2024 | $ 55.94M | 5.32 | $ 10.52M |
9/30/2024 | $ 65.83M | 5.66 | $ 11.63M |
6/30/2024 | $ 80.89M | 5.73 | $ 14.12M |
3/31/2024 | $ 93.17M | 10.47 | $ 8.9M |
12/31/2023 | $ 109.6M | 9.55 | $ 11.47M |
9/30/2023 | $ 91.71M | 10.59 | $ 8.66M |
6/30/2023 | $ 102.17M | 10.07 | $ 10.14M |
3/31/2023 | $ 119.52M | 17.78 | $ 6.72M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for OVID THERAPEUTICS INC is calculated as follows: AssetsC [ $ 90.35M ] / LiabilitesC [ $ 17.96M ]
(=) Current Ratio [ 5.03 ]
Minimum
Dec 31, 2020
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |